APA (7th ed.) Citation

T, N., M, K., K, U., W, H., H, D., H, K., . . . H, K. (2022). Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial. Journal of clinical medicine, 12(1), . https://doi.org/10.3390/jcm12010292

Chicago Style (17th ed.) Citation

T, Nanki, Kawazoe M, Uno K, Hirose W, Dobashi H, Kataoka H, Mimura T, Hagino H, and Kono H. "Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial." Journal of Clinical Medicine 12, no. 1 (2022). https://doi.org/10.3390/jcm12010292.

MLA (9th ed.) Citation

T, Nanki, et al. "Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial." Journal of Clinical Medicine, vol. 12, no. 1, 2022, https://doi.org/10.3390/jcm12010292.